Pharmacology, Efficacy and Safety of a Triple-Secured Fibrinogen Concentrate in Children Less than or Equal to 12 Years with Afibrinogenaemia.
Claudia Djambas KhayatMohamed El KhorassaniSelin AytaçAnnie HarrocheAmel DahmaneSonia PujolCéline HenrietPhilippe de MoerlooseFrançoise BrideyPublished in: Thrombosis and haemostasis (2020)
Individually tailored dosing was efficacious in children who exhibited a lower IVR and shorter t 1/2 than those previously reported in adolescent and adult patients emphasising the importance of individualised dose optimisation.
Keyphrases